Jun 23, 2022 8:00am EDT Pasithea Therapeutics to Participate in the H.C. Wainwright 1st Annual Mental Health Conference: Neuropsychiatry, Psychedelics and Beyond
Mar 30, 2022 4:15pm EDT Pasithea Therapeutics Announces Financial and Business Results for the Fourth Quarter and Full Year 2021 and Business Update for 2022
Feb 24, 2022 8:00am EST Pasithea Therapeutics Announces Plans to Open Three New Clinics in the UK by Mid-2022
Feb 09, 2022 8:00am EST Pasithea Therapeutics Strengthens its Scientific Advisory Board with the Appointment of Preeminent Scientist Dr. Daniel Weinberger
Feb 03, 2022 8:00am EST Pasithea Therapeutics Initiates New Chemical Entity Drug Development Program in Multiple Sclerosis
Jan 26, 2022 8:00am EST Pasithea Therapeutics Announces Opening of Mental Health Clinic in Los Angeles and Broadens Focus Beyond Ketamine Treatments
Dec 21, 2021 8:00am EST Pasithea Therapeutics Opens Second Ketamine Therapy Clinic in the United Kingdom
